Literature DB >> 19407220

Minireview: role of protein methylation and demethylation in nuclear hormone signaling.

Susan C Wu1, Yi Zhang.   

Abstract

Nuclear hormone receptors (NRs) are transcription factors responsible for mediating the biological effects of hormones during development, metabolism, and homeostasis. Induction of NR target genes is accomplished through the assembly of hormone-bound NR complexes at target promoters and coincides with changes in histone modifications that promote transcription. Some coactivators and corepressors of NR can enhance or inhibit NR function by covalently modifying histones. One such modification is methylation, which plays important roles in transcriptional regulation. Histone methylation is catalyzed by histone methyltransferases and reversed by histone demethylases. Recent studies have uncovered the importance of these enzymes in the regulation of NR target genes. In addition to histones, these enzymes have nonhistone substrates and can methylate and demethylate NRs and coregulatory proteins in order to modulate their function. This review discusses recent progress in our understanding of the role of methylation and demethylation of histones, NRs, and their coregulators in NR-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407220      PMCID: PMC2737564          DOI: 10.1210/me.2009-0131

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  110 in total

1.  Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP.

Authors:  N Vo; C Fjeld; R H Goodman
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation.

Authors:  María J Barrero; Sohail Malik
Journal:  Mol Cell       Date:  2006-10-20       Impact factor: 17.970

3.  Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.

Authors:  H Chen; R J Lin; R L Schiltz; D Chakravarti; A Nash; L Nagy; M L Privalsky; Y Nakatani; R M Evans
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

4.  Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation.

Authors:  M D Mostaqul Huq; Pawan Gupta; Nien-Pei Tsai; Roger White; Malcolm G Parker; Li-Na Wei
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

5.  Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways.

Authors:  Ray-Chang Wu; Jun Qin; Ping Yi; Jiemin Wong; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell       Date:  2004-09-24       Impact factor: 17.970

6.  Lysine methylation of nuclear co-repressor receptor interacting protein 140.

Authors:  M D Mostaqul Huq; Sung Gil Ha; Helene Barcelona; Li-Na Wei
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

Review 7.  Minireview: nuclear receptors and breast cancer.

Authors:  Suzanne D Conzen
Journal:  Mol Endocrinol       Date:  2008-04-16

8.  A proteomic analysis of arginine-methylated protein complexes.

Authors:  François-Michel Boisvert; Jocelyn Côté; Marie-Chloé Boulanger; Stéphane Richard
Journal:  Mol Cell Proteomics       Date:  2003-10-07       Impact factor: 5.911

Review 9.  Coactivators and nuclear receptor transactivation.

Authors:  Irene M Wolf; Marjet D Heitzer; Melanie Grubisha; Donald B DeFranco
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

Review 10.  Review of the in vivo functions of the p160 steroid receptor coactivator family.

Authors:  Jianming Xu; Qingtian Li
Journal:  Mol Endocrinol       Date:  2003-06-12
View more
  20 in total

Review 1.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

2.  A motif in HSP90 and P23 that links molecular chaperones to efficient estrogen receptor α methylation by the lysine methyltransferase SMYD2.

Authors:  Wolfgang M J Obermann
Journal:  J Biol Chem       Date:  2018-09-06       Impact factor: 5.157

Review 3.  Male germline transmits fetal alcohol epigenetic marks for multiple generations: a review.

Authors:  Dipak K Sarkar
Journal:  Addict Biol       Date:  2015-01-12       Impact factor: 4.280

4.  Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.

Authors:  Smita Awasthi; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2012-02-11       Impact factor: 4.102

Review 5.  The road less traveled: new views of steroid receptor action from the path of dose-response curves.

Authors:  S Stoney Simons; Carson C Chow
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

6.  Hypoxia-induced methylation of a pontin chromatin remodeling factor.

Authors:  Jason S Lee; Yunho Kim; Jinhyuk Bhin; Hi-Jai R Shin; Hye Jin Nam; Seung Hoon Lee; Jong-Bok Yoon; Olivier Binda; Or Gozani; Daehee Hwang; Sung Hee Baek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

7.  Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.

Authors:  Xi Zhang; Kaori Tanaka; Jiusheng Yan; Jing Li; Danni Peng; Yuanyuan Jiang; Zhe Yang; Michelle C Barton; Hong Wen; Xiaobing Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

Review 8.  Epigenetics of neural repair following spinal cord injury.

Authors:  Elisa M York; Audrey Petit; A Jane Roskams
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 9.  What's new in estrogen receptor action in the female reproductive tract.

Authors:  Sylvia C Hewitt; Wipawee Winuthayanon; Kenneth S Korach
Journal:  J Mol Endocrinol       Date:  2016-02       Impact factor: 5.098

Review 10.  Epigenetic codes of PPARγ in metabolic disease.

Authors:  Shigeki Sugii; Ronald M Evans
Journal:  FEBS Lett       Date:  2011-05-19       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.